Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 10/20 | 0.61 |
| ▸ | ADH1C | P00326 | 7/20 | 0.61 |
| ▸ | ADH1B | P00325 | 1/20 | 0.61 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27736931 | 0.98 | ADH1A (0.63) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL21183508 | 0.98 | ADH1A (0.63) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL27716098 | 0.98 | ADH1A (0.63) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| Lithium Ion SCHEMBL30062922 | 0.81 | ADH1A (0.59) | ADH1AADH1CADH1BADH4 | |
| SCHEMBL19975581 | 0.77 | ADH1A (0.54) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL19975558 | 0.77 | ADH1A (0.54) | ADH1AADH1CADH1BALDH1A1ATM | |
| SCHEMBL28226157 | 0.77 | ADH1A (0.54) | ADH1AADH1CADH1B | |
| SCHEMBL9463243 | 0.77 | ADH1A (1.00) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL10486684 | 0.76 | ADH1C (0.41) | ADH1AADH1CADH1B | |
| SCHEMBL601670 | 0.75 | FDPS (0.45) | ADH1AADH1CADH1BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110062753-A | Antiviral compounds | 哈普洛根有限责任公司 | 2019-07-26 | — | — | CN | disclosed |
| EP-3512836-A1 | ANTIVIRAL COMPOUNDS | Haplogen GmbH (AT) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018050631-A1 | ANTIVIRAL COMPOUNDS | HAPLOGEN GMBH (AT) | 2018-03-22 | — | — | WO | disclosed |